\-\ Texto\\:\\ \ \(0\)\
\-\ pe\\ \\â\\€\\“\\ noncontributory\ \(0\)\
\-\ \\ \\ \\ \\ \\ \\ \\ \\ \\ \\ \\ \\ \\ \\ \\ \\ \\ \\ \\ \\ \\ \\ \\ \\ \\ \\ \\ \\ \\ \\ \\ \\ \\ \\ \\ \\ \\ \\ \\ \\ \\ \\ \\ \\ \\ \\ \\ \\ \\ \\ \\ \\ \\ \\ \\ labs\\ \\â\\€\\“\\ pt\\ 14\\.1\\ \\ ptt\\ 34\\.5\\ \\ inr\\ 1\\.1\\ \\ cbc\\ 6\\.6\\/15\\.2\\/44\\/180\ \(0\)\
\-\ \\ \\ \\ \\ \\ \\ \\ \\ \\ \\ \\ \\ \\ \\ \\ \\ \\ \\ \\ \\ \\ \\ \\ \\ \\ \\ \\ \\ \\ \\ \\ \\ \\ \\ \\ \\ \\ \\ \\ \\ \\ \\ \\ \\ \\ \\ \\ \\ \\ \\ \\ \\ \\ \\ \\ \\ \\ \\ \\ \\ \\ \\ \\ \\ \\ \\ \\ a\\-1\\-fetoprotein\\ 1\\.9\\ \\ ast\\/alt\\ 37\\/33\\ \\ alk\\ phos\\ 78\\ \\ alb\\ 4\\.6\\ \\ tprotein\\ 7\\.9\ \(0\)\
\-\ \\ \\ \\ \\ \\ \\ \\ \\ \\ \\ \\ \\ \\ \\ \\ \\ \\ \\ \\ \\ \\ \\ \\ \\ \\ \\ \\ \\ \\ \\ \\ \\ \\ \\ \\ \\ \\ \\ \\ \\ \\ \\ \\ \\ \\ \\ \\ \\ \\ \\ \\ \\ \\ \\ \\ \\ \\ \\ \\ \\ \\ \\ \\ \\ \\ \\ \\ tbili\\ 1\\.1\\ \\ dbili\\ 0\\ \\ iron\\ 98\\ \\ tibc\\ 393\\ \\ fe\\ sat\\ 24\\.9\\%\ \(0\)\
\-\ unknown\\ at\\ this\\ time\\â\\€\\¦resection\\ vs\\.\\ transplantation\\.\\ \\ other\\ options\\ include\\ chemotherapy\\ and\\ radioablation\\.\ \(0\)\
\-\ 2\\.9\\ cm\\ mass\\ in\\ r\\ lobe\\ of\\ liver\\,\\ l\\ liver\\ lobe\\ atrophy\ \(0\)\
\-\ hcc\ \(0\)\
\-\ hepatocellular\\ carcinoma\ \(28\)\
\-\ \\ \\ \\ \\ \\ \\ \\ \\ \\ \\ \\ \\ \\ \\ \\ \\ \\ \\ \\ \\ \\ \\ \\ \\ \\ \\ \\ \\ \\ \\ \\ \\ \\ \\ \\ \\ \\ \\ \\ \\ \\ \\ \\ \\ \\ \\ \\ \\ \\ \\ \\ \\ \\ \\ focal\\ nodular\\ hyperplasia\ \(0\)\
\-\ \\ \\ \\ \\ \\ \\ \\ \\ \\ \\ \\ \\ \\ \\ \\ \\ \\ \\ \\ \\ \\ \\ \\ \\ \\ \\ \\ \\ \\ \\ \\ \\ \\ \\ \\ \\ \\ \\ \\ \\ \\ \\ \\ \\ \\ \\ \\ \\ \\ \\ \\ \\ \\ \\ metastatic\\ disease\ \(0\)\
\-\ 65\\ yo\\ male\\ with\\ h\\/o\\ hemochromatosis\ \(1\)\
\-\ hcc\\ occurs\\ in\\ 19\\-24\\%\\ of\\ pts\\ with\\ hemochromatosis\\,\\ which\\ is\\ a\\ 20\\ to\\ 200\\ fold\\ increased\\ risk\\ compared\\ with\\ the\\ general\\ population\\ \\(similar\\ to\\ that\\ of\\ pts\\ with\\ cirrhosis\\ secondary\\ to\\ viral\\ hepatitis\\)\\.\\ \\ risk\\ factors\\ include\\ advancing\\ age\\ \\(\\>50\\)\\,\\ male\\ sex\\,\\ and\\ the\\ presence\\ of\\ cirrhosis\\.\\ \\ lft\\â\\€\\™s\\ are\\ often\\ normal\\ as\\ the\\ pathophysiology\\ is\\ not\\ an\\ inflammatory\\ process\\.\\ \\ hcc\\ is\\ the\\ leading\\ cause\\ of\\ death\\ in\\ pts\\ with\\ hemochromatosis\\ \\(approximately\\ 30\\%\\)\\.\\ \\ other\\ causes\\ include\\ cardiac\\ failure\\ resulting\\ from\\ iron\\ deposition\\ in\\ the\\ heart\\ tissue\\ and\\ hepatic\\ failure\\.\\ \ \(0\)\
\-\ fnh\\ is\\ almost\\ always\\ seen\\ in\\ women\\ of\\ childbearing\\ age\\ \\(90\\%\\)\\ and\\ is\\ frequently\\ associated\\ with\\ oral\\ contraceptive\\ use\\.\ \(0\)\
\-\ the\\ remainder\\ of\\ the\\ abdominal\\ pelvic\\ ct\\ was\\ neg\\ for\\ malignancy\\ and\\ pts\\ unremarkable\\ physical\\ exam\\ \\(non\\-cachectic\\)\\ makes\\ mets\\ unlikely\\.\ \(0\)\
\-\ Keywords\\ by\\ value\\:\\ \ \(0\)\
\-\ pts\\:\\ 0\\.36079042388822935\ \(0\)\
\-\ hemochromatosis\\:\\ 0\\.2685728591285944\ \(0\)\
\-\ hcc\\:\\ 0\\.25978534055038\ \(0\)\
\-\ iron\\:\\ 0\\.16511761340097744\ \(0\)\
\-\ cirrhosis\\:\\ 0\\.15775864735484454\ \(0\)\
\-\ include\\:\\ 0\\.133659383950359\ \(0\)\
\-\ tprotein\\:\\ 0\\.11442750378057358\ \(0\)\
\-\ failure\\:\\ 0\\.11370139507909875\ \(0\)\
\-\ radioablation\\:\\ 0\\.1106511431651753\ \(0\)\
\-\ 393\\:\\ 0\\.1077219703057705\ \(0\)\
\-\ fe\\:\\ 0\\.1077219703057705\ \(0\)\
\-\ risk\\:\\ 0\\.10700680502141705\ \(0\)\
\-\ dbili\\:\\ 0\\.10532866181578739\ \(0\)\
\-\ tibc\\:\\ 0\\.10532866181578739\ \(0\)\
\-\ the\\:\\ 0\\.10458940510442138\ \(0\)\
\-\ liver\\:\\ 0\\.10331185615812102\ \(0\)\
\-\ advancing\\:\\ 0\\.1033051483198809\ \(0\)\
\-\ contraceptive\\:\\ 0\\.1033051483198809\ \(0\)\
\-\ of\\:\\ 0\\.10257627482105518\ \(0\)\
\-\ is\\:\\ 0\\.10253246633365509\ \(0\)\
\-\ childbearing\\:\\ 0\\.10155230120038912\ \(0\)\
\-\ alb\\:\\ 0\\.09517911089916394\ \(0\)\
\-\ fnh\\:\\ 0\\.09420630635509471\ \(0\)\
\-\ age\\:\\ 0\\.09402125319467484\ \(0\)\
\-\ in\\:\\ 0\\.09313900761849694\ \(0\)\
\-\ lft\\:\\ 0\\.09245345923560293\ \(0\)\
\-\ sex\\:\\ 0\\.09019760597205734\ \(0\)\
\-\ with\\:\\ 0\\.0879750549607013\ \(0\)\
\-\ pathophysiology\\:\\ 0\\.08768965173866584\ \(0\)\
\-\ transplantation\\:\\ 0\\.087130977886215\ \(0\)\
\-\ tbili\\:\\ 0\\.08659511351679333\ \(0\)\
\-\ fold\\:\\ 0\\.08659511351679333\ \(0\)\
\-\ lobe\\:\\ 0\\.08654586253042429\ \(0\)\
\-\ ptt\\:\\ 0\\.08558485715222534\ \(0\)\
\-\ 200\\:\\ 0\\.08255880670048872\ \(0\)\
\-\ neg\\:\\ 0\\.08075778758498982\ \(0\)\
\-\ inr\\:\\ 0\\.0801013080866043\ \(0\)\
\-\ alk\\:\\ 0\\.07830850095396967\ \(0\)\
\-\ other\\:\\ 0\\.07777313848724965\ \(0\)\
\-\ phos\\:\\ 0\\.07749627155200714\ \(0\)\
\-\ and\\:\\ 0\\.0773655404251903\ \(0\)\
\-\ hepatocellular\\:\\ 0\\.07698142696959157\ \(0\)\
\-\ hepatitis\\:\\ 0\\.07698142696959157\ \(0\)\
\-\ mets\\:\\ 0\\.07698142696959157\ \(0\)\
\-\ 78\\:\\ 0\\.07624514871980526\ \(0\)\
\-\ deposition\\:\\ 0\\.07554798378736097\ \(0\)\
\-\ sat\\:\\ 0\\.07532358765335638\ \(0\)\
\-\ makes\\:\\ 0\\.075102963062024\ \(0\)\
\-\ death\\:\\ 0\\.07345996473570253\ \(0\)\
\-\ 98\\:\\ 0\\.07252859164374602\ \(0\)\
\-\ atrophy\\:\\ 0\\.0708433507896416\ \(0\)\
\-\ population\\:\\ 0\\.0708433507896416\ \(0\)\
\-\ always\\:\\ 0\\.0706861410761344\ \(0\)\
\-\ viral\\:\\ 0\\.06907074918308016\ \(0\)\
\-\ hyperplasia\\:\\ 0\\.06826681304506439\ \(0\)\
\-\ options\\:\\ 0\\.06750928437466025\ \(0\)\
\-\ women\\:\\ 0\\.06738717322265296\ \(0\)\
\-\ almost\\:\\ 0\\.06726618753505931\ \(0\)\
\-\ male\\:\\ 0\\.06667922689364991\ \(0\)\
\-\ noncontributory\\:\\ 0\\.06667744069309704\ \(0\)\
\-\ leading\\:\\ 0\\.06656279494968867\ \(0\)\
\-\ unlikely\\:\\ 0\\.06633646427081571\ \(0\)\
\-\ remainder\\:\\ 0\\.06589518392281718\ \(0\)\
\-\ 65\\:\\ 0\\.06407470731741102\ \(0\)\
\-\ factors\\:\\ 0\\.06334014623083999\ \(0\)\
\-\ cbc\\:\\ 0\\.062476225707532494\ \(0\)\
\-\ resulting\\:\\ 0\\.06231006077763675\ \(0\)\
\-\ pe\\:\\ 0\\.06190362415703192\ \(0\)\
\-\ frequently\\:\\ 0\\.061665668622812864\ \(0\)\
\-\ compared\\:\\ 0\\.06053659015951096\ \(0\)\
\-\ general\\:\\ 0\\.0601108170243973\ \(0\)\
\-\ oral\\:\\ 0\\.05997190721829398\ \(0\)\
\-\ 90\\:\\ 0\\.059834451991856434\ \(0\)\
\-\ nodular\\:\\ 0\\.059630930796012636\ \(0\)\
\-\ hepatic\\:\\ 0\\.059630930796012636\ \(0\)\
\-\ occurs\\:\\ 0\\.05903864142152841\ \(0\)\
\-\ pelvic\\:\\ 0\\.058533700162238494\ \(0\)\
\-\ use\\:\\ 0\\.05729384018287721\ \(0\)\
\-\ vs\\:\\ 0\\.057125903723784\ \(0\)\
\-\ similar\\:\\ 0\\.05707039897224847\ \(0\)\
\-\ unknown\\:\\ 0\\.05674221052387712\ \(0\)\
\-\ causes\\:\\ 0\\.056581142807643994\ \(0\)\
\-\ process\\:\\ 0\\.056161047623300285\ \(0\)\
\-\ to\\:\\ 0\\.056159823104105576\ \(0\)\
\-\ malignancy\\:\\ 0\\.05605809137645818\ \(0\)\
\-\ cardiac\\:\\ 0\\.05560452730283368\ \(0\)\
\-\ pt\\:\\ 0\\.053888884329683244\ \(0\)\
\-\ presence\\:\\ 0\\.05380223811291259\ \(0\)\
\-\ chemotherapy\\:\\ 0\\.05317000416618192\ \(0\)\
\-\ 50\\:\\ 0\\.05229455621804543\ \(0\)\
\-\ heart\\:\\ 0\\.05206559365441282\ \(0\)\
\-\ labs\\:\\ 0\\.05187779568485149\ \(0\)\
\-\ 30\\:\\ 0\\.05108198511452347\ \(0\)\
\-\ cause\\:\\ 0\\.0510119750596111\ \(0\)\
\-\ inflammatory\\:\\ 0\\.05063345500427577\ \(0\)\
\-\ unremarkable\\:\\ 0\\.05019974565764857\ \(0\)\
\-\ often\\:\\ 0\\.048859425285092316\ \(0\)\
\-\ 20\\:\\ 0\\.048308161454955346\ \(0\)\
\-\ approximately\\:\\ 0\\.0477791180023826\ \(0\)\
\-\ yo\\:\\ 0\\.046780996470368576\ \(0\)\
\-\ carcinoma\\:\\ 0\\.04479004236489705\ \(0\)\
\-\ focal\\:\\ 0\\.04479004236489705\ \(0\)\
\-\ secondary\\:\\ 0\\.04438347322543499\ \(0\)\
\-\ cm\\:\\ 0\\.04300463585497031\ \(0\)\
\-\ metastatic\\:\\ 0\\.041068127510589525\ \(0\)\
\-\ abdominal\\:\\ 0\\.0409540510890436\ \(0\)\
\-\ physical\\:\\ 0\\.040601846068670025\ \(0\)\
\-\ increased\\:\\ 0\\.040491734003888315\ \(0\)\
\-\ associated\\:\\ 0\\.03946756101550912\ \(0\)\
\-\ tissue\\:\\ 0\\.03928054513523684\ \(0\)\
\-\ exam\\:\\ 0\\.03769480689613341\ \(0\)\
\-\ seen\\:\\ 0\\.03525306366023212\ \(0\)\
\-\ which\\:\\ 0\\.03404884130118501\ \(0\)\
\-\ that\\:\\ 0\\.03249526485039278\ \(0\)\
\-\ disease\\:\\ 0\\.03143211182979632\ \(0\)\
\-\ normal\\:\\ 0\\.03057314582789787\ \(0\)\
\-\ as\\:\\ 0\\.03008209512690864\ \(0\)\
\-\ from\\:\\ 0\\.029739301411395486\ \(0\)\
\-\ not\\:\\ 0\\.02956098194582629\ \(0\)\
\-\ an\\:\\ 0\\.028633995438432047\ \(0\)\
\-\ mass\\:\\ 0\\.028602295702716815\ \(0\)\
\-\ ct\\:\\ 0\\.028507653229440363\ \(0\)\
\-\ are\\:\\ 0\\.028413688231356773\ \(0\)\
\-\ at\\:\\ 0\\.028283257095435766\ \(0\)\
\-\ was\\:\\ 0\\.026096544192632912\ \(0\)\
\-\ this\\:\\ 0\\.02573023759990033\ \(0\)\
\-\ for\\:\\ 0\\.022695660156652808\ \(0\)\
